Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, ALL, Adult, Combination therapy, Antibody Therapy, Lymphomas, Non-Hodgkin lymphoma, Clinical Practice (Health Services and Quality), Clinical Research, Health outcomes research, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, Diseases, Indolent lymphoma, Therapy sequence, Real-world evidence, Aggressive lymphoma, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Adverse Events, Non-Biological therapies, Study Population, Human
Ibrahim Muhsen, MD1, Anjali S. Advani, MD2, Gregory W Roloff, MD3, Nikeshan Jeyakumar, MD4, Katharine Miller, PhD, MPH5*, Amy Zhang, PhD5*, Katherine C. Sutherland, PA-C6*, Michael R. Grunwald, MD7, Vamsi K. Kota, MD8, Jacob Boccucci, MD9*, Matthew Ulrickson, MD10, Joshua Sasine, MD11, Ibrahim Aldoss, MD12, Tamer Othman, MD13, Sumithira Vasu, MD, MBBS14, Ran Reshef, MD, MSc15, Marlise R. Luskin, MD16, Evan C. Chen, MD17, Chenyu Lin, MD18, Amelia Langston, MD19, Ryan D. Cassaday, MD20, Noam E. Kopmar, MD21, Stephanie B. Tsai22, Timothy E O'Connor, MD22, Talal Hilal, MD23, Rawan Faramand, MD24, Jae H. Park, MD25, Yannis K. Valtis, MD26, Melhem M. Solh, MD27, Evandro Bezerra, MD28, Jessica T. Leonard, MD29, Simone E. Dekker, MD, PhD30, Navneet Majhail, MD, MS, FASTCT31, Minoo Battiwalla, MD31, Shahbaz A. Malik, MD32, John Mathews, MD33*, Paul Shaughnessy, MD34, Luke Mountjoy, DO35, Rasmus T. Hoeg, MD36*, Caspian H. Oliai, MD37, Vishal Gupta, MD38*, Divya Koura, MD39, Kaitlyn C Dykes, MD, BS40, Aaron C. Logan, MD, PhD41, Muthu V. Kumaran, MD42*, Wendy Stock, MD43, Marc Schwartz, MD44, Veronika Bachanova, MD, PhD45, Sean Tracy, MD, PhD46, Kristen M. O'Dwyer, MD47, Jozal Moore, MD48, Catherine J. Lee, MD, MSc49, Maria Silvina Odstrcil Bobillo, MD50*, Noelle Frey, MD, MS51, Matthew P Connor, MD52, Omer Jamy, MD53, Michael Daunov, DO54, Abdullah Ladha, MD55*, George Yaghmour, MD55, Clayton Jackson, MD56*, Vivian Irrizary Gatell, MD57*, Olalekan O. Oluwole, MD, MPH, MBBS58, Bhagirathbhai R. Dholaria, MBBS59, Vinod Pullarkat, MD60, Akil Merchant, MD61, Bijal D Shah, MD62, Lori Muffly, MD63 and LaQuisa Hill, MD1,64*
1Baylor College of Medicine, Houston, TX
2Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
3University of Chicago, Chicago, IL
4Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA
5Stanford University School of Medicine, Stanford, CA
6Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Kenmore, WA
7Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
8Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA
9Georgia Cancer Center, Augusta University, Augusta, GA
10Banner/MD Anderson Cancer Center, Gilbert, AZ
11Cedars-Sinai Medical Center, Los Angeles, CA
12Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
13Hematology/HCT, City of Hope, San Lorenzo, CA
14Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
15Division of Hematology & Oncology, Columbia University Medical Center, New York
16Center for Adult Leukemia, Dana-Farber Cancer Institute, Boston, MA
17Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
18Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC
19Emory University, Winship Cancer Institute, Atlanta, GA
20University of Washington and Fred Hutchinson Cancer Center, Seattle, WA
21Fred Hutchinson Cancer Center, Seattle, WA
22Loyola University Medical Center, Chicago, IL
23Division of Hematology, Mayo Clinic, Phoenix, AZ
24Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
25Cell Therapy Service and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
26Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
27BMT Group of Georgia, Atlanta, GA
28Division of Hematology, The Ohio State University, Columbus, OH
29Knight Cancer Institute, Oregon Health and Science University, Portland, OR
30Department of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR
31Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN
32Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX
33Sarah Cannon Transplant and Cellular Therapy Network, HCA Healthcare, Dallas, TX
34Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
35The Colorado Blood Cancer Institute a part of Sarah Cannon Cancer Institute at Presbyterian/St Luke's Medical Center, Denver, CO
36Comprehensive Cancer Center, University of California, Davis, Sacramento, CA
37Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA
38University of California Los Angeles, Los Angeles
39UCSD Moores Cancer Center, San Diego, CA
40University of California San Diego, San Diego, CA
41Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
42University of Arkansas for Medical Sciences, Little Rock, AR
43Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
44Division of Hematology, University of Colorado, Denver, CO
45Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
46Center for Immunology and Division of Hematology, Oncology, and Transplantation, University of Minnesota, Saint Paul, MN
47Wilmot Cancer Institute, University of Rochester, Rochester, NY
48Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
49Huntsman Cancer Institute, University of Utah, Mercer Island, WA
50Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
51University of Pennsylvania, Philadelphia, PA
52Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
53O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL
54Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
55Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
56Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
57Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX
58Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
59Vanderbilt University Medical Center, Nashville, TN
60Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
61Division of Hematology and Cellular Therapy, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
62Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
63Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
64Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Methodist Hospital, Houston, TX
Swetha Kambhampati Thiruvengadam, MD1, Reid W. Merryman, MD2, Yan Wang3*, Charles Gaulin, MBBS4, Evandro Bezerra, MD5, Timothy Voorhees, MD, MSc5, Madhav R Seshadri, MD6, Ayo S Falade, MD, MBA7, Alma Habib, MD5, Amy A. Ayers, MPH4*, Megumi Bailey8*, Annette Brown9*, Neil Bailey, MSc10, Krish Patel, MD10, Charalambos Andreadis, MD11, Adam S Kittai, MD5, Caron A. Jacobson, MD, MMSc2, Joycelynne Michelle Palmer, PhD3*, Stephen J. Forman, MD, FACP12, Loretta Nastoupil4* and Lihua E. Budde, MD, PhD13
1City of Hope National Medical Center, Yorba Linda, CA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3City of Hope, Duarte, CA
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Division of Hematology, The Ohio State University, Columbus, OH
6University of California San Francisco, San Francisco, CA
7Mass General Brigham Salem Hospital, Salem, MA
8Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
9City of Hope National Medical Center, Duarte, CA
10Swedish Cancer Institute, Seattle, WA
11Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA
12Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
13Department of Hematology and HCT, City of Hope, Duarte, CA
Matthew J. Cortese, MD, MPH, MD, MPH1, Megan M Herr, PhD2, Nisha Nair, MS, MPH2*, Jason Romancik3*, Natalie Grover, MD4, Rahul S Bhansali, MD5, Colin Thomas, MD6, Tamara K Moyo, MD7*, Vaishalee P Kenkre, MD8, Thomas Ollila, MD9, Brian Hess, MD10, Lindsey Fitzgerald, MD11, Geoffrey Shouse, PhD, DO12, Matthew Matasar, MD, MS13, Kaitlin Annunzio, DO14, James A Davis, PharmD15*, Christy Jesme, MD11*, Ari Pelcovits, MD16, Megan Melody, MD17, Jonathan Moreira, MD18, Adam Yuh Lin, MD PhD19, Shuo Ma, MD, PhD20, Jane N Winter, MD21, Alex Niu, MD22*, Alexey V. Danilov, MD, PhD23, Nirav N. Shah, MD24, Deborah M. Stephens, DO25, Jonathon B. Cohen, MD, MS26, Leo I. Gordon, MD27, Stefan K. Barta, MD28, Narendranath Epperla, MD, MS29 and Reem Karmali, MD21
1Department of Medicine - Lymphoma Section, Department of Cancer Genetics & Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Department of Medicine (Transplant & Cellular Therapy Center), Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, Georgia
4University of North Carolina, Chapel Hill, NC
5Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
6Thomas Jefferson University Hospital, Philadelphia, PA
7Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
8Carbone Cancer Center, Univ. of Wisconsin, Madison, WI
9Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI
10Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
11Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
12City of Hope Cancer Center, Duarte, CA
13Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New York, NY
14The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
15Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
16Rhode Island Hospital, Providence, RI
17Feinberg School of Medicine, Northwestern University, Chicago, IL
18Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
19Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
20Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL
21Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
22Department of Medicine (Lymphoma Section), Roswell Park Comprehensive Cancer Center, Buffalo, NY
23Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
24Medical College of Wisconsin, Brookfield, WI
25University of North Carolina Chapel Hill, Chapel Hill, NC
26Winship Cancer Institute, Emory University, Atlanta, GA
27Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Department of Medicine, Division of Hematology/Oncology, Chicago, IL
28Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
29Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Dasom (Caroline) Lee, MD1*, Swetha Kambhampati Thiruvengadam, MD2, Maria Silvina Odstrcil Bobillo, MD3*, Babatunde Adedokun, MD, PhD4*, Mazyar Shadman, MD, MPH5*, Amanda L. Olson, MD6, Alex F. Herrera, MD7, Catherine J. Lee, MD, MSc8, Caron A. Jacobson, MD, MMSc9, Matthew Bye, MPH10*, Mehdi Hamadani, MD10, Soyoung Kim, PhD11*, Saurabh Dahiya, MD, FACP12*, Zhen-Huan Hu, MPH4*, Kelly Speth, PhD4*, Christina To, MD4*, Debbie L. Mirjah, MD13*, Timothy Best, PhD4*, Frederick L. Locke, MD14, Nausheen Ahmed, MD15*, Michael T. Tees, MD, MPH16, Marcelo C. Pasquini, MD, MS17 and Sairah Ahmed, MD18
1Division of Hematology, Stanford University, Palo Alto, CA
2City of Hope National Medical Center, Yorba Linda, CA
3University of Utah, Salt Lake City, UT
4Kite, a Gilead Company, Santa Monica, CA
5University of Washington, Fred Hutchinson Cancer Research Center and Medical Oncology Division, Seattle, WA
6The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
8University of Washington, 5Fred Hutchinson Cancer Center and Medical Oncology Division, Seattle, WA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
10Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI
11Center for International Blood and Marrow Transplant Registry (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
12Division of Hematology, Stanford University, Stanford, CA
13Kite Pharma, a Gilead Company, Santa Monica, CA
14Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
15Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
16HCA Healthcare, Sarah Cannon Transplant and Cellular Therapy Network, Denver, CO
17Dana Farber Cancer Institute, Boston, MA
18Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
Jiasheng Wang, MD1, Shakthi Bhaskar, MD2, Babatunde Adedokun, MD, PhD3*, Olalekan O. Oluwole, MD, MPH, MBBS2, Leland Metheny, MD4, Amy Moskop, MD5, Caron A. Jacobson, MD, MMSc6, Geoffrey Shouse, PhD, DO7, Sairah Ahmed, MD8, Armin Ghobadi, MD9, Saurabh Dahiya, MD10, Jiali Yan11*, Zhen-Huan Hu, MPH11*, Timothy Best, PhD11*, Jenny J. Kim, MD, MS11, Debbie L. Mirjah, MD11*, Marcelo C. Pasquini, MD, MS12 and Frederick L. Locke, MD13
1The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
3Kite Pharma, a Gilead Company, NEWBURY PARK, CA
4Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
5Department of Pediatrics, Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7City of Hope Cancer Center, Duarte, CA
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Division of Oncology, Washington University School of Medicine, St. Louis, MO
10Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Mountain View, CA
11Kite Pharma, a Gilead Company, Santa Monica, CA
12Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
13Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
Nicolas Gower1*, Cécile Pizot2*, Marie-Emilie Dourthe, MD, PhD3,4*, Thomas Gastinne, MD5*, Gabriel Brisou, MD, PhD6,7,8*, Stephanie Guidez9*, Jean-Jacques Tudesq, MD, MSc10*, Adrien Chauchet11*, Laura Herbreteau12*, Arnaud Campidelli, MD13*, Pierre Sesques, MD14*, Edmond Chiche15*, Francois Xavier Gros, MD16*, Amandine Durand, MD17*, Marion Lubnau18*, Arthur Sterin19*, Roberta Di Blasi, MD, PhD20*, Jacques-Olivier Bay, MD, PhD21*, Alexandra Marquet22*, Elodie Gat23*, Roch Houot, MD, PhD24*, Franck Morschhauser, MD, PhD25 and Jérôme Paillassa26*
1Clinical Hematology, Lille University Hospital, Lille, France
2LYSARC biostatistical team, Lyon, France
3Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
4INSERM U1151, Institut Necker Enfants Malades (INEM), Paris, France
5Clinical Hematology, Nantes University Hospital, Nantes, FRA
6Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France
7Department of Hematology, Institut Paoli-Calmettes, Marseille, France
8Institut Paoli-Calmettes, Marseille, France
9Department of hematology, Poitiers university hospital, Poitiers, France
10Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
11Besançon University Hospital, Besançon, France
12Clinical Hematology, Brest University Hospital, Brest, France
13Clinical Hematology, Nancy University Hospital, Vand Uvre Les Nancy, FRA
14CHU Lyon-Sud, Hospices Civils de Lyon, Lyon, France
15Nice University Hospital, Nice, FRA
16CHU BORDEAUX, Merignac, FRA
17Department of Hematology, University Hospital F. Mitterrand, Dijon, France
18Pediatric hematology, Nancy University Hospital, Nancy, France
19Department of Pediatric Hematology, Immunology and Oncology, APHM, La Timone Children Hospital, Department of Pediatric Hematology, Immunolog, Marseille, France
20Department of Hematology, Assistance Publique Hôpitaux de Paris - Hôpital Saint-Louis, University of Paris, PARIS, France
21BMT Unit, Clermont-Ferrand University Hospital, Clermont-Ferrand, France
22Lysarc, Lyon Sud Hospital, Biostatistics Unit, Pierre-Bénite, Lyon, France
23Department of biostatistics, Lymphoma Academic Research Organisation (LYSARC), Pierre Bénite, France
24Rennes university hospital - Hospital Pontchaillou, Rennes, France
25Centre Hospitalier Régional Universitaire de Lille, Lille, France
26Centre Hospitalier Universitaire d' Angers, ANGERS, France